Briev
Live
Business

Analyst flags Ambuja Cements, Asahi India Glass and Pfizer as top buys for August 6

Aakash K Hindocha of Nuvama Wealth Management recommends buying Ambuja Cements, Asahi India Glass and Pfizer, citing technical breakouts and bullish price patterns.

Aakash K Hindocha, Vice President of Research at Nuvama Professional Clients Group/Nuvama Wealth Management, identified three equities as the strongest buy candidates for August 6, 2026. Ambuja Cements is trading at a last close price of ₹445, with a stop-loss at ₹427 and a target of ₹478, after a decisive breakout from a five-month symmetrical triangle. Asahi India Glass, priced at ₹926, carries a stop-loss of ₹892 and a target of ₹990, following a breakout above an eight-month declining trendline and a close above its 200-day moving average.

Pfizer, quoted at ₹4,908, has a stop-loss of ₹4,700 and a target of ₹5,280, reflecting a breakout from a 12-month downward sloping trendline and a reclaimed 200-day average. The analyst also provided a brief outlook on the Nifty and Bank Nifty indices, noting modest green performance and potential support levels around their 200-day moving averages. These recommendations are presented as the analyst’s personal view and do not represent the publication’s stance.

Why it matters

Investors get specific entry, stop-loss and target levels for three stocks deemed poised for short-term gains.

In this story

stock recommendationtechnical breakoutAmbuja CementsAsahi India GlassPfizerNiftyBank Nifty